Factor Inhibitor Activity (Plasma/Serum)
This test measures the activity level of a protein that naturally inhibits blood clotting factors, helping assess bleeding disorders or coagulation pathway function.
["This test helps diagnose or monitor conditions affecting blood clotting."]
Key facts at a glance
- LOINC
- 40744-5
- Short code
- Fact Inhib XXX PPP Ql
- Synonyms
- Fact Inhib XXX PPP Ql
- Category
- chemistry
- Sample
- plasma
- Container
- Lavender-top (EDTA) or Green-top (Heparin)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- coag
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
What Is This Test Used For?
Blood clotting involves a complex series of reactions where proteins like factors interact to stop bleeding. This test specifically evaluates the activity of an inhibitor protein that can interfere with these reactions. It may be used to diagnose conditions such as acquired or congenital bleeding disorders, where abnormal inhibitor levels can lead to excessive bleeding or clotting issues.
How Is the Test Performed?
A blood sample is drawn from a vein, typically in your arm. The sample is then processed to separate plasma or serum, where the inhibitor activity is measured using specialized laboratory techniques. The method may involve detecting how well the inhibitor blocks normal clotting factors under controlled conditions.
Why Might You Need This Test?
Your doctor may recommend this test if you have symptoms like unexplained bruising, prolonged bleeding from cuts, excessive menstrual bleeding, or if you’ve been diagnosed with a suspected bleeding disorder. It may also be used in patients undergoing blood clotting treatments or those with known inhibitor-related conditions.
What Are Common Conditions Linked to This Test?
Abnormal levels of this inhibitor can be linked to bleeding disorders such as acquired hemophilia, where the immune system mistakenly produces an inhibitor against clotting factors. It may also be relevant in patients with known coagulation pathway deficiencies or those on anticoagulant medications.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
This test plays a critical role in diagnosing bleeding disorders caused by inhibitor proteins. Elevated or abnormal inhibitor activity can indicate conditions like acquired hemophilia, where the immune system attacks clotting factors, leading to bleeding problems. Proper evaluation helps guide treatment decisions, such as managing bleeding episodes or adjusting medications.
Short name
Factor Inhibitor Activity
Frequently asked questions
What does a high or low result mean?
How often is this test repeated?
Can lifestyle changes affect this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy